1 S&P 500 Stock for Long-Term Investors and 2 We Turn Down

Nasdaq Rebound: Buy 2 Monster Growth Stocks Up 20% Since Late March

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

The Nasdaq Just Did Something It Hasn't Done Since 2020, and Here's What Could Happen Next

Stocks Extend ‘Astonishing’ Rally as Middle East Tensions Ease Further

Nasdaq scores longest winning streak since 1992 as historic stock-market comeback continues